Wednesday, November 11, 2026

OpenAI Chief Scientist: AI Models Approaching Indefinite Autonomous Operation

OpenAI's chief scientist Jakub Pachocki says AI models are nearing the capability to work indefinitely without human intervention, marking a shift from code assistance to autonomous research systems. The company envisions entire research labs operating within data centers as models gain extended runtime capabilities.

LM Salvado

March 25, 2026

OpenAI Chief Scientist: AI Models Approaching Indefinite Autonomous Operation
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

OpenAI's chief scientist Jakub Pachocki stated the company is approaching models capable of working indefinitely in a coherent manner, similar to human researchers. "I think we are getting close to a point where we'll have models capable of working indefinitely in a coherent way just like people do," Pachocki said.

The transition represents a move from basic code assistance tools to autonomous AI systems that run experiments independently without continuous human oversight. Pachocki projects a future where "you kind of have a whole research lab in a data center," signaling OpenAI's ambition to automate knowledge work at scale.

The shift stems from improvements in base model capability rather than specialized architecture. Pachocki noted that simple boosts in all-round capability enable models to work longer without assistance. This differs from earlier approaches that relied on narrow tools for specific tasks.

The development raises deployment questions as autonomous systems gain extended runtime. Pachocki acknowledged that very powerful models should operate in sandboxes isolated from systems they could break or exploit. "I think this is a big challenge for governments to figure out," he said regarding the regulatory framework for such systems.

The timing coincides with broader enterprise AI adoption. Companies are deploying specialized systems ranging from military intelligence platforms to retail pricing algorithms, creating infrastructure for autonomous operations beyond controlled research environments.

OpenAI's focus on extended autonomous runtime addresses a key limitation in current AI deployment: the need for frequent human intervention to maintain task coherence. Models that can operate for hours or days without guidance could transform enterprise workflows currently requiring human oversight at regular intervals.

The sandbox approach Pachocki described suggests OpenAI recognizes the risks of deploying powerful autonomous systems with unrestricted access to external resources. The containment strategy mirrors practices in cybersecurity and malware analysis where untrusted code runs in isolated environments.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
  1. [1]News articleMIT Technology Review
    OpenAI is throwing everything into building a fully automated researcher
  2. [2]News articleYahoo Finance· January 22, 2026
    4 Medical Supply Stocks Poised to Gain in a Prospering Industry
  3. [3]News articleYahoo Finance· February 24, 2026
    Agentic AI Foundation Welcomes 97 New Members As Demand for Open, Collaborative Agent Standardization Increases
  4. [4]Press releaseGlobeNewswire· March 13, 2026
    Agero Enters into Agreement to Acquire Urgently, for $5.50 in Cash Per Share, Expanding Tech-Driven Roadside Assistance Across Automotive, Fleet, Rental, and Insurance Markets
  5. [5]News articleYahoo Finance· November 26, 2025
    AI to Reshape the Global Technology Landscape in 2026, Says TrendForce
  6. [6]News articleMIT Technology Review
    Can quantum computers now solve health care problems? We’ll soon find out.
  7. [7]News articleYahoo Finance· January 30, 2026
    Lilly selects Pennsylvania as home for its newest injectable medicine and device manufacturing facility
  8. [8]Press releaseGlobeNewswire· March 23, 2026
    LLMs in Education Market to Grow from $7.49B in 2026 to Over $35B by 2030 - Cloud Solutions Address Infrastructure Costs in Education
  9. [9]News articleNasdaq· March 23, 2026
    Stocks Sharply Higher as President Trump Seeks to End Iran War
  10. [10]News articleIEEE Spectrum
    Transforming Data Science With NVIDIA RTX PRO 6000 Blackwell Workstation Edition
  11. [11]News articleCrunchbase News
    US Startup Funding Slows Sharply In March
  12. [12]News articleYahoo Finance· February 27, 2026
    Why Rare Earth Magnets Are the Real Battlefield Between the U.S. and China

In this story

LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com